Table of Contents
mPharma, the Accra-based healthcare startup co-founded by Ghanaian entrepreneur Gregory Rockson, has received a strategic investment from an SME-focused platform backed by British International Investment (BII).
The deal received from Growth Investment Partners (GIP) Ghana Ltd is set to support mPharma’s expansion of its QualityRx franchise model into Francophone markets, including Togo and Benin, and reinforces its mission to improve availability, affordability, and efficiency in the pharmaceutical supply chain. The deal marks a significant step in Ghana’s emergence as a hub for health-tech innovation and impact-driven investment across Africa.
Scaling healthcare access
The investment aligns with mPharma’s objective of delivering measurable social impact: within its network, 72 percent of patients report lower medicine prices and 96 percent experience fewer stock-outs, while chronic care programs, such as the Diabetes Test & Treat initiative, have helped 80 percent of enrolled patients achieve optimal glycemic control within six months.
mPharma establishes an integrated retail network by collaborating with independent pharmacies. Its asset-light franchise model uses proprietary software to control pricing, minimize stock-outs, and simplify inventory management. With this backing, mPharma will be able to scale operations, extending its reach outside of Ghana and solidifying its standing as the region's top health-tech innovator.
Gregory Rockson said the investment “accelerates our mission to close healthcare access gaps across the region,” while Jacob Kholi, CEO of GIP Ghana, added that the firm “supports businesses delivering measurable social and economic outcomes, scaling solutions that improve communities while sustaining growth.”
Partnership for sustainable growth
Founded in 2013 by Rockson, Daniel Shoukimas, and James Finucane, mPharma has been transforming access to medicines across West Africa, while managing pharmaceutical inventories for African mom-and-pop pharmacies and offering unique financial and inventory management solutions to hospitals and patients directly.
GIP’s latest support signals growing confidence in West Africa’s healthcare SME ecosystem, providing patient capital and expertise in governance and operations. The partnership also strengthens collaboration with local distributors like Ubipharm, GAPOB, and Laborex to ensure regulatory compliance and smooth logistics across new markets.
